U-Chart Analysis:TAIKO PHARMACEUTICAL CO.,LTD.:4574

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index TAIKO PHARMACEUTICAL CO.,LTD. Go to web site 4574 Medicals 東証プライム December 1, 2000 2009.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents 4,532 5,484 3,105 5,796 4,945
Other Current AssetsHelp 4,229 3,625 4,451 7,987 14,877
Tangible Fixed AssetsHelp 3,271 3,581 6,397 7,113 9,447
Intangible Fixed AssetHelp 27 1 222 299 319
Investments and OthersHelp 855 529 871 1,340 2,170
Total AssetsHelp 12,914 13,220 15,046 22,535 31,758
Total Current LiabilitiesHelp 4,148 4,460 4,261 5,914 8,913
Total Long-term LiabilitiesHelp 803 2,021 2,741 3,814 64
Shareholder's EquityHelp 7,963 6,739 8,044 12,807 22,781
Total LiabilitiesHelp 12,914 13,220 15,046 22,535 31,758

TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales 6,292 6,120 5,040 11,299 17,583
Total Sales 6,292 6,120 5,040 11,299 17,583
Cost of SalesHelp 2,626 3,543 3,961 7,973 5,263
Other Costs and RevenueHelp 2,769 6,187 5,973 12,919 8,468
Total CostsHelp 5,395 9,730 9,934 20,892 13,731
Net RevenueHelp 3,666 2,577 1,079 3,326 12,320
Earnings Before TaxHelp 565 -3,563 -4,869 -8,887 5,374
Net IncomeHelp 897 -3,610 -4,894 -9,593 3,852
Net Income 897 -3,610 -4,894 -9,593 3,852

TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help 362 -307 -1,993 -1,596 -1,517
Investing Cash Flow(ICF)Help -5 1,166 190 -1,622 -2,760
Financing Cash FlowHelp -1,181 1,539 -997 3,959 -649
Exchange Difference of Cash and Cash EquivalentsHelp 112 49 76 82 -22
Net Increase and Decrease in Cash and Cash Equivalentsn -712 2,447 -2,724 823 -4,948

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

TAIKO PHARMACEUTICAL CO.,LTD.
Finatext Holdings Ltd.
SATO HOLDINGS CORPORATION
EBARA CORPORATION
Keio Corporation

Company where related level is highHelp

KYORIN Pharmaceutical Co., Ltd.
StemRIM Inc.
MORISHITA JINTAN CO.,LTD.
Mochida Pharmaceutical Co.,Ltd.
Sumitomo Pharma Co., Ltd.
NANO MRNA Co., Ltd.
Renascience Inc.
Kidswell Bio Corporation
ROHTO PHARMACEUTICAL CO.,LTD.
GNI Group Ltd.